Clinical Trial Update: A Study on the Safety, Preliminary Efficacy, and Cellular Kinetics of Allo-CD7 CAR-T Cells in T1DM [EARLY_Phase 1]

View source ↗

Summary

An early-phase study assessing the safety, preliminary efficacy, and cellular kinetics of Allo-CD7 CAR-T cells in individuals with Type 1 diabetes. The trial is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Allo-CD7 CAR-T cells

Snippet

Sponsor: Nanjing Bioheng Biotech Co., Ltd. | Conditions: Type 1 Diabetes | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING